Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page for the trial now displays a 403 Forbidden error, removing the previous study content and contacts and leaving only site chrome and the error message.SummaryDifference20%

- Check30 days agoChange DetectedFooter revision label updated from v3.6.6 to v3.7.0, indicating a CMS update; no study text or page content appears to be affected.SummaryDifference0.1%

- Check44 days agoChange DetectedAn updated site revision tag (v3.6.6) replaces the previous version (v3.6.5), signaling a minor maintenance update to the page without altering study details.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing v3.6.4. This indicates a new software release version for the site rather than a change to study details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4. This indicates a minor, internal update to the page version rather than a modification to its visible content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.